BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26763556)

  • 1. Evaluating predictors of competing risk outcomes when censoring depends on time-dependent covariates, with application to safety and efficacy of HIV treatment.
    Lok JJ; Hughes MD
    Stat Med; 2016 Jun; 35(13):2183-94. PubMed ID: 26763556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of the cumulative incidence function under multiple dependent and independent censoring mechanisms.
    Lok JJ; Yang S; Sharkey B; Hughes MD
    Lifetime Data Anal; 2018 Apr; 24(2):201-223. PubMed ID: 28238045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of dynamic treatment regimes via inverse probability weighting.
    Hernán MA; Lanoy E; Costagliola D; Robins JM
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):237-42. PubMed ID: 16611197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the cumulative mean function for history process with time-dependent covariates and censoring mechanism.
    Deng D
    Stat Med; 2016 Nov; 35(25):4624-4636. PubMed ID: 27222200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression modeling of semicompeting risks data.
    Peng L; Fine JP
    Biometrics; 2007 Mar; 63(1):96-108. PubMed ID: 17447934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semiparametric regression on cumulative incidence function with interval-censored competing risks data.
    Bakoyannis G; Yu M; Yiannoutsos CT
    Stat Med; 2017 Oct; 36(23):3683-3707. PubMed ID: 28608412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating competing adverse and beneficial outcomes using a mixture model.
    Lau B; Cole SR; Moore RD; Gange SJ
    Stat Med; 2008 Sep; 27(21):4313-27. PubMed ID: 18416435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods of competing risks flexible parametric modeling for estimation of the risk of the first disease among HIV infected men.
    Nouri S; Mahmoudi M; Mohammad K; Mansournia MA; Yaseri M; Akhtar-Danesh N
    BMC Med Res Methodol; 2020 Jan; 20(1):17. PubMed ID: 31996148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic prediction of cumulative incidence functions by direct binomial regression.
    Grand MK; de Witte TJM; Putter H
    Biom J; 2018 Jul; 60(4):734-747. PubMed ID: 29577376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian Two-Part Tobit Models with Left-Censoring, Skewness, and Nonignorable Missingness.
    Dagne GA; Huang Y
    J Biopharm Stat; 2015; 25(4):714-30. PubMed ID: 24905924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection bias.
    Howe CJ; Cole SR; Chmiel JS; Muñoz A
    Am J Epidemiol; 2011 Mar; 173(5):569-77. PubMed ID: 21289029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semiparametric estimation of treatment effect with time-lagged response in the presence of informative censoring.
    Lu X; Tsiatis AA
    Lifetime Data Anal; 2011 Oct; 17(4):566-93. PubMed ID: 21706378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weighted estimation of the accelerated failure time model in the presence of dependent censoring.
    Cho Y; Ghosh D
    PLoS One; 2015; 10(4):e0124381. PubMed ID: 25909753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial.
    Schackman BR; Scott CA; Sax PE; Losina E; Wilkin TJ; McKinnon JE; Swindells S; Weinstein MC; Freedberg KA
    Clin Infect Dis; 2007 Oct; 45(8):1062-70. PubMed ID: 17879926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of the time aspect into the liability-threshold model for case-control-family data.
    Cederkvist L; Holst KK; Andersen KK; Glidden DV; Frederiksen K; Kjaer SK; Scheike TH
    Stat Med; 2017 May; 36(10):1599-1618. PubMed ID: 28114748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing semi-competing risks data with missing cause of informative terminal event.
    Zhou R; Zhu H; Bondy M; Ning J
    Stat Med; 2017 Feb; 36(5):738-753. PubMed ID: 27813148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of censoring in competing risks analysis of the subdistribution hazard.
    Donoghoe MW; Gebski V
    BMC Med Res Methodol; 2017 Apr; 17(1):52. PubMed ID: 28376736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection Bias Due to Loss to Follow Up in Cohort Studies.
    Howe CJ; Cole SR; Lau B; Napravnik S; Eron JJ
    Epidemiology; 2016 Jan; 27(1):91-7. PubMed ID: 26484424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competing risks and time-dependent covariates.
    Cortese G; Andersen PK
    Biom J; 2010 Feb; 52(1):138-58. PubMed ID: 20029852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A flexible parametric approach for estimating continuous-time inverse probability of treatment and censoring weights.
    Saarela O; Liu ZA
    Stat Med; 2016 Oct; 35(23):4238-51. PubMed ID: 27139501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.